Published in Histol Histopathol on July 01, 2005
Molecular pathology of age-related macular degeneration. Prog Retin Eye Res (2008) 3.35
Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest Ophthalmol Vis Sci (2007) 2.36
CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. Am J Pathol (2010) 2.25
CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J Neurosci (2011) 1.95
Immunopathological aspects of age-related macular degeneration. Semin Immunopathol (2008) 1.63
Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition. Proc Natl Acad Sci U S A (2006) 1.52
Animal models of age related macular degeneration. Mol Aspects Med (2012) 1.39
Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD). Prog Retin Eye Res (2010) 1.39
Ccl2/Cx3cr1-deficient mice: an animal model for age-related macular degeneration. Ophthalmic Res (2008) 1.36
Common variation in the SERPING1 gene is not associated with age-related macular degeneration in two independent groups of subjects. Mol Vis (2009) 1.26
Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging. Invest Ophthalmol Vis Sci (2013) 1.17
The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples. Invest Ophthalmol Vis Sci (2007) 1.17
Human HtrA1 in the archived eyes with age-related macular degeneration. Trans Am Ophthalmol Soc (2007) 1.15
The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples. Ophthalmology (2008) 1.07
Age- and light-dependent development of localised retinal atrophy in CCL2(-/-)CX3CR1(GFP/GFP) mice. PLoS One (2013) 1.06
Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci (2016) 0.97
Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases. Mediators Inflamm (2015) 0.96
Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation. J Immunol (2013) 0.95
Copy number variations in candidate genes in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 0.95
Cellular and 3D optical coherence tomography assessment during the initiation and progression of retinal degeneration in the Ccl2/Cx3cr1-deficient mouse. Exp Eye Res (2011) 0.95
Potential Sources and Roles of Adaptive Immunity in Age-Related Macular Degeneration: Shall We Rename AMD into Autoimmune Macular Disease? Autoimmune Dis (2014) 0.91
Genetic mechanisms and age-related macular degeneration: common variants, rare variants, copy number variations, epigenetics, and mitochondrial genetics. Hum Genomics (2012) 0.90
Peroxisome Proliferator-Activated Receptor Expression in Murine Models and Humans with Age-related Macular Degeneration. Open Biol J (2009) 0.90
Chlamydia pneumoniae infection, complement factor H variants and age-related macular degeneration. Br J Ophthalmol (2008) 0.87
The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis. Methods Mol Biol (2013) 0.87
Hypocellular scar formation or aberrant fibrosis induced by an intrastromal corneal ring: a case report. J Med Case Rep (2011) 0.84
Disruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina. ASN Neuro (2015) 0.81
Prospective study of common variants in CX3CR1 and risk of macular degeneration: pooled analysis from 5 long-term studies. JAMA Ophthalmol (2014) 0.81
Early degeneration of photoreceptor synapse in Ccl2/Cx3cr1-deficient mice on Crb1(rd8) background. Synapse (2013) 0.80
Fractalkine Signaling Attenuates Perivascular Clustering of Microglia and Fibrinogen Leakage during Systemic Inflammation in Mouse Models of Diabetic Retinopathy. Front Cell Neurosci (2017) 0.75
The future of genetic studies of complex human diseases. Science (1996) 64.76
Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science (1998) 18.23
Searching for genetic determinants in the new millennium. Nature (2000) 17.50
Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet (1999) 17.09
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol (1999) 13.55
Chemokines: a new classification system and their role in immunity. Immunity (2000) 13.03
An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med (2003) 6.61
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol (2003) 5.22
Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology (2000) 5.18
Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol (1998) 4.91
Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology (1993) 3.99
The promise of comparative genomics in mammals. Science (1999) 3.67
Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med (2004) 3.15
Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (2003) 3.04
Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood (2001) 2.87
Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet (1998) 2.82
Recent advances in chemokines and chemokine receptors. Crit Rev Immunol (1999) 2.78
Chemokines: agents for the immunotherapy of cancer? Nat Rev Immunol (2002) 2.68
Genetic polymorphism in CX3CR1 and risk of HIV disease. Science (2000) 2.38
Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res (2001) 2.33
Histopathology of age-related macular degeneration. Mol Vis (1999) 2.27
Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol (2001) 2.27
Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest (2003) 2.27
Genetic factors of age-related macular degeneration. Prog Retin Eye Res (2004) 2.17
Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol (2000) 2.07
The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol (1998) 2.04
The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J (2004) 2.04
Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res (2003) 1.87
Macrophages related to Bruch's membrane in age-related macular degeneration. Eye (Lond) (1990) 1.87
Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis (2002) 1.87
Chemokines, inflammation and the immune system. Ther Immunol (1994) 1.86
The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J Leukoc Biol (2003) 1.84
Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science (2000) 1.70
Chemokine biology in cancer. Semin Immunol (2003) 1.68
Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv Ophthalmol (1999) 1.54
Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. Ophthalmology (1998) 1.46
Granulomatous reaction to Bruch's membrane in age-related macular degeneration. Arch Ophthalmol (1994) 1.46
Histologic features of the early stages of age-related macular degeneration. A statistical analysis. Ophthalmology (1992) 1.37
Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation. J Immunol (2002) 1.33
Risk factors for age-related macular degeneration: an update. Curr Opin Ophthalmol (2002) 1.33
Association of the apolipoprotein E gene with age-related macular degeneration: possible effect modification by family history, age, and gender. Mol Vis (2000) 1.31
Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication. Kidney Int (1999) 1.25
Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia-reperfusion brain injury in the rat. Eur J Neurosci (2002) 1.24
Chemokines: progress toward identifying molecular targets for therapeutic agents. Trends Biotechnol (1996) 1.20
Age-related macular degeneration: epidemiology and optimal treatment. Drugs Aging (2002) 1.19
Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest Ophthalmol Vis Sci (2004) 1.19
Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration. Am J Ophthalmol (2001) 1.10
Correlation of histologic 2-dimensional reconstruction and confocal scanning laser microscopic imaging of choroidal neovascularization in eyes with age-related maculopathy. Arch Ophthalmol (2000) 1.09
The genealogic approach to human genetics of disease. Cancer J (2001) 1.06
Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia. J Neurovirol (2002) 0.96
Genomic organization and evolution of the CX3CR1/CCR8 chemokine receptor locus. J Biol Chem (2003) 0.95
Apolipoprotein E polymorphisms in age-related macular degeneration in an Italian population. Ophthalmic Res (2001) 0.95
Cellular response in subretinal neovascularization induced by bFGF-impregnated microspheres. Invest Ophthalmol Vis Sci (1999) 0.93
Mechanisms of age-related macular degeneration. Ophthalmol Clin North Am (2002) 0.90
Macrophages eyed in macular degeneration. Nat Med (2003) 0.90
Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation. J Allergy Clin Immunol (2004) 0.90
Scavenger receptors and modified lipoproteins: fatal attractions? IUBMB Life (2000) 0.85
Age-related maculopathy: its genetic basis. Eye (Lond) (2001) 0.84
[Distribution of HIV-1 coreceptor CX3CR1 allelic polymorphisms in general population, HIV-1 high-risk group and HIV-1 carriers of Chinese indigenous Han and Uygur people]. Zhonghua Liu Xing Bing Xue Za Zhi (2003) 0.77
Strategies for mapping susceptibility genes in age-related maculopathy. Eye (Lond) (2001) 0.77
Genetic susceptibility to ageing-associated diseases. C R Biol (2002) 0.76
Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol (1989) 6.53
Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol (1982) 6.39
Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest (1997) 5.77
Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol (1981) 5.09
Ocular explosion after peribulbar anesthesia: case report and experimental study. Ophthalmology (1997) 3.59
Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. Am J Ophthalmol (1983) 3.42
Ocular explosions from periocular anesthetic injections: a clinical, histopathologic, experimental, and biophysical study. Ophthalmology (1999) 3.35
Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res (1983) 2.90
Pathologic features of senile macular degeneration. Ophthalmology (1985) 2.73
Assessment of neonatal conjunctivitis with a direct immunofluorescent monoclonal antibody stain for Chlamydia. JAMA (1986) 2.69
Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol (1982) 2.61
Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology (1988) 2.59
Brief report: uveitis caused by Tropheryma whippelii (Whipple's bacillus) N Engl J Med (1995) 2.47
Conjunctival lesions in adults. A clinical and histopathologic review. Cornea (1987) 2.43
Unilateral Duane's retraction syndrome (Type 1). Arch Ophthalmol (1982) 2.40
Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch Ophthalmol (1981) 2.34
A histopathologic study of Best's macular dystrophy. Arch Ophthalmol (1982) 2.27
A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis. Ophthalmology (1996) 2.27
Ocular and orbital involvement in leukemia. Surv Ophthalmol (1983) 2.26
Senile macular degeneration: a histopathologic study. Trans Am Ophthalmol Soc (1977) 2.20
Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol (1983) 2.19
Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol (1999) 2.18
Clinicopathologic correlation of a macular hole treated by cortical vitreous peeling and gas tamponade. Ophthalmology (1994) 2.16
Pathologic findings in pathologic myopia. Retina (1992) 2.14
Lesions of the caruncle: a clinicohistopathologic study. Surv Ophthalmol (1979) 2.08
Bilateral Duane's retraction syndrome. A clinical-pathologic case report. Arch Ophthalmol (1980) 2.01
The histology of human glaucoma cupping and optic nerve damage: clinicopathologic correlation in 21 eyes. Ophthalmology (1979) 1.97
Histologic studies of the vasculature of the anterior optic nerve. Am J Ophthalmol (1976) 1.96
Regulation of keratinocyte growth factor gene expression by interleukin 1. J Biol Chem (1994) 1.95
X-linked ocular albinism. An oculocutaneous macromelanosomal disorder. Arch Ophthalmol (1976) 1.94
Primary adenocarcinoma of the lacrimal gland. A retrospective study. Ophthalmology (1993) 1.93
A histopathologic review of 168 cases of preretinal membrane. Am J Ophthalmol (1977) 1.93
Clinicopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade. Retina (1992) 1.91
Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol (1997) 1.90
Detection of herpes simplex viral DNA in the iridocorneal endothelial syndrome. Arch Ophthalmol (1994) 1.88
White centered hemorrhages: their significance. Ophthalmology (1980) 1.88
Epibulbar tumors in childhood. Am J Ophthalmol (1975) 1.88
Sebaceous gland carcinoma. Review of 40 cases. Arch Ophthalmol (1984) 1.83
Neurotoxic effects of cisplatin therapy. Arch Neurol (1982) 1.83
Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology (1989) 1.76
Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium. J Clin Invest (1993) 1.75
Leber hereditary optic neuropathy. Electron microscopy and molecular genetic analysis of a case. Ophthalmology (1995) 1.74
Senile disciform degeneration of the macula. Retinal arterialization of the fibrous plaque demonstrated clinically and histopathologically. Arch Ophthalmol (1971) 1.74
Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina (1994) 1.72
Transforming growth factor beta. A biologic chorioretinal glue. Arch Ophthalmol (1989) 1.71
Retinal pathologic changes in multiple sclerosis. Retina (1994) 1.71
Clinical biochemical and pathologic correlations in Bietti's crystalline dystrophy. Am J Ophthalmol (1994) 1.70
Posterior capsule opacification in pseudophakic eyes. Ophthalmology (1983) 1.66
Toxicity of intravitreous ceftazidime in primate retina. Arch Ophthalmol (1992) 1.63
Histopathology of commotio retinae. Retina (1992) 1.62
CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J Immunol (1997) 1.62
Asperillosis of the orbit. Report of ten cases and review of the literature. Arch Ophthalmol (1969) 1.56
The role of apoptosis in the pathogenesis of Fuchs endothelial dystrophy of the cornea. Arch Ophthalmol (2001) 1.56
Clinicopathologic correlation of surgically removed macular hole opercula. Am J Ophthalmol (1995) 1.55
Detection of human papillomavirus type 6/11 DNA in conjunctival papillomas by in situ hybridization with radioactive probes. Hum Pathol (1987) 1.54
Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc (1981) 1.52
The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol (1994) 1.51
Bietti's crystalline dystrophy. A clinicopathologic correlative study. Arch Ophthalmol (1989) 1.51
The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol (1983) 1.51
Ocular manifestations of graft-vs-host disease. Ophthalmology (1983) 1.50
Histopathologic study of nine branch retinal vein occlusions. Arch Ophthalmol (1982) 1.48
Endophthalmitis due to Propionibacterium acnes sequestered between IOL optic and posterior capsule. Ophthalmic Surg (1989) 1.48
Frequency of ocular metastases in patients dying of cancer in eye bank populations. Br J Ophthalmol (1996) 1.46
Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology (1987) 1.46
Granulomatous reaction to Bruch's membrane in age-related macular degeneration. Arch Ophthalmol (1994) 1.46
Idiopathic epiretinal membranes. Ultrastructural characteristics and clinicopathologic correlation. Ophthalmology (1989) 1.45
Oxidative damage in age-related macular degeneration. Histol Histopathol (2007) 1.44
Brown tumor of the orbit associated with primary hyperparathyroidism. Am J Ophthalmol (1980) 1.44
Massive hemorrhage complicating age-related macular degeneration. Clinicopathologic correlation and role of anticoagulants. Ophthalmology (1986) 1.44
Histopathologic features of idiopathic macular holes and cysts. Ophthalmology (1990) 1.43
Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. Am J Ophthalmol (2000) 1.42
Histopathologic studies of ischemic optic neuropathy. Trans Am Ophthalmol Soc (2000) 1.41
Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J Clin Invest (1994) 1.41
Elevated intraocular pressure, pigment dispersion and dark hypopyon in endogenous endophthalmitis from Listeria monocytogenes. Surv Ophthalmol (1992) 1.41
Provision of anesthesia with single application of lidocaine 2% gel. J Cataract Refract Surg (1999) 1.40
Morphology, pathology, and surgery of idiopathic vitreoretinal macular disorders. A review. Retina (1990) 1.40
Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics. Am J Pathol (1989) 1.38
Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Bone Marrow Transplant (2004) 1.37
A histopathologic study of macular cysts and holes. Retina (1981) 1.36
Autosomal-dominant fundus flavimaculatus. Clinicopathologic correlation. Ophthalmology (1990) 1.35
Ophthalmologic manifestations of carotid occlusive disease. Eye (Lond) (1991) 1.34
Temporal arteritis. A clinicopathologic study. Ophthalmology (1986) 1.34
The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol (1989) 1.34
Endogenous Serratia marcescens endophthalmitis with dark hypopyon: case report and review. Surv Ophthalmol (2001) 1.33
Autosomal recessively inherited ocular albinism. A new form of ocular albinism affecting females as severely as males. Arch Ophthalmol (1978) 1.33
Ocular clinicopathologic study of gyrate atrophy. Am J Ophthalmol (1991) 1.32
VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma. Arch Ophthalmol (1999) 1.31
Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization. Submacular Surgery Trials Research Group. Arch Ophthalmol (1998) 1.30
Morphometric analysis of the macula in eyes with disciform age-related macular degeneration. Retina (2002) 1.29
Modulation of keratinocyte growth factor and its receptor in reepithelializing human skin. J Exp Med (1995) 1.29
Demonstration of papillomavirus capsid antigen in human conjunctival neoplasia. Arch Ophthalmol (1986) 1.28
Histopathologic study of the effect of retinal detachment surgery on 49 eyes obtained post mortem. Am J Ophthalmol (1987) 1.28
Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Arch Ophthalmol (1991) 1.28
Clinicopathologic findings in a patient with serpiginous choroiditis and treated choroidal neovascularization. Retina (1989) 1.27
Choroidal neovascularization. Ophthalmology (1986) 1.27
Parafoveal retinal telangiectasis. Light and electron microscopy studies. Trans Ophthalmol Soc U K (1980) 1.27
Angioid streaks in Ehlers-Danlos syndrome. Arch Ophthalmol (1966) 1.27
Factors in the successful surgical management of basal cell carcinoma of the eyelids. Am J Ophthalmol (1981) 1.26
Ocular BB injuries. Ophthalmology (1984) 1.26